Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery
The Journal of Immunology · 2026
DOI: 10.1093/jimmun/vkaf305 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Luciana Conde und 32 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia de Linfócitos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Single-Cell Analysis, Antibodies, Monoclonal, Memory B Cells, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: GIISER-Brazil/Bill and Melinda Gates Foundation, Stavros Niarchos Foundation Institute for Global Infectious Disease at the Rockefeller University, Yale University.
Abstract (Originalsprache)
The SARS-CoV-2 pandemic underscored the need for innovative approaches to study humoral immunity and isolate monoclonal antibodies (mAbs) with diagnostic and therapeutic potential. Current methods for repertoire analysis at the clonal level require large-scale recombinant mAb production, limiting accessibility and delaying functional insight. We developed a single-cell culture (SCC) platform that enables profiling of human memory B cells and direct recovery of functional mAbs. Using samples from COVID-19 convalescent and vaccinated donors, we optimized SCCs with NB21 feeder cells, R848, and IL-2, achieving efficient clonal expansion and antibody secretion in short-term cultures. Screening and pseudovirus neutralization assays were performed directly with culture supernatants, bypassing the need for early recombinant antibody production. Antigen-baited cytometry sorting enriched spike-specific memory B cells by ∼30-fold. Among 592 isolated mAbs, 53% bound the Wuhan spike, targeting the receptor-binding domain (28%), N-terminal domain (15%), or other regions (57%). Cross-reactivity analysis revealed that 40% of anti-spike mAbs recognized all tested variants of concern. VH/VL sequencing uncovered convergent rearrangements, including public V3-30 and V3-53/V3-66 clones, consistent with global findings. Two public receptor-binding domain–specific antibodies demonstrated broad neutralization when produced recombinantly. Together, these results validate the SCC system as a streamlined approach for unbiased repertoire analysis and functional mAb isolation. More broadly, the platform provides a practical framework for linking B cell clonal composition with antigen specificity and serum antibody responses. By reducing costs and simplifying workflows, it expands opportunities for antibody discovery and immunoepidemiological studies, fostering wider global participation in therapeutic antibody research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biologia de Linfócitos, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
- Fundação Oswaldo Cruz, Fiocruz Ceara, Pasteur-Fiocruz Center on Immunology and Immunotherapy, Eusébio, CE, Brazil.
- Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA.
- Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
ORCID-Profile: Adriana Bonomo
Förderung
- GIISER-Brazil/Bill and Melinda Gates Foundation
- Stavros Niarchos Foundation Institute for Global Infectious Disease at the Rockefeller University
- Yale University
- Instituto Serrapilheira
- Brazilian research funding agencies FAPERJ
- CNPq
- CAPES
- FINEP
Zitieren
APA
Conde, L., Oliveira, D. L., Maciel, G., Castro, F., de Oliveira Albuquerque, A., Rodrigues, D. A., Mëllo, Y., Meira de Assis, G., Gabrielle, B., Ferreira, S. S., Cunha, M. S., Navas, C., Emiliano, M. C., Rocha, M. N., Soares, B., Tostes, L., Caloba, P., Maia, B., Bastos de Oliveira, F. M., …, & Vale, A. M. (2026). Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf305
Vancouver
Conde L, Oliveira DL, Maciel G, Castro F, de Oliveira Albuquerque A, Rodrigues DA, et al. Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkaf305
BibTeX
@article{Conde2026,
author = {Conde, Luciana and Oliveira, Debora L and Maciel, Gabriela and Castro, Fernando and de Oliveira Albuquerque, Aline and Rodrigues, Danielle A and Mëllo, Yare and Meira de Assis, Gustavo and Gabrielle, Bárbara and Ferreira, Suyane S and Cunha, Marcela S and Navas, Carlena and Emiliano, Manuela C and Rocha, Marcele N and Soares, Barbara and Tostes, Lucas and Caloba, Philippe and Maia, Bruno and Bastos de Oliveira, Francisco M and Tanuri, Amilcar and Ferreira, Orlando C and Castineiras, Terezinha M and Martins da Silva, João Hermínio and Echevarria, Juliana and T Bozza, Marcelo and Castilho, Leda R and da Costa, Luciana J and Felicori, Liza F and Nobrega, Alberto and Victora, Gabriel D and Lucas, Carolina and Bonomo, Adriana and Vale, André M},
title = {Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery},
journal = {The Journal of Immunology},
year = {2026},
doi = {10.1093/jimmun/vkaf305}
}
EUVIMED